NB100-65022

antibody from Novus Biologicals

Targeting: CSF2 GM-CSF, GMCSF

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Functional assay (Data presented on provider website)

Antibody Data

Product number

NB100-65022

Provider

Novus Biologicals

Proper citation

Novus Cat#NB100-65022, RRID:AB_963738

Product name

Mouse Monoclonal GM-CSF Antibody

Antibody type

Monoclonal

Description

Protein A purified. NB100-65022 recognizes recombinant and native human granulocyte macrophage colony stimulating factor (GM-CSF). Human Granulocyte colony stimulating factor (GM-CSF) is a 14.6kDa glycoprotein, which is produced by T cells, macrophages, fibroblasts and endothelial cells. GM-CSF is involved in the stimulation of proliferation and differentiation of granulocyte and macrophage progenitor cells. The neutralisation dose (ND50) of this batch, as determined by the proliferation of TF-1 cells, is approximately 0.3-0.5 ug/ml in the presence of 0.5 ng/ml of recombinant human GM-CSF. The ND50 may vary depending on conditions.

Reactivity

Human

Host

Mouse

Isotype

IgG

Vial size

0.05 mg

Concentration

1.0 mg/ml

Storage

Store at -20C. Avoid freeze-thaw cycles.

References

Submitted references

GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Nebiker CA, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser RA, Rosso R, Bolli M, Oertli D, von Holzen U, Adamina M, Muraro MG, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Spagnoli GC
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 15;20(12):3094-106